Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 3 (March)

1. Safety and efficacy of a recombinant hepatitis E vaccine.
   N Engl J Med, 356(9): 895-903. [Abstract] [Full-text]
2. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.
   Virol J, 4: 16. [Abstract] [Full-text]
3. Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C.
   J Infect Dis, 195(7): 973-9. [Abstract] [Full-text]
4. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.
   Hepatology, 45(3): 579-87. [Abstract] [Full-text]
5. The effects of HCV infection and management on health-related quality of life.
   Hepatology, 45(3): 806-16. [Abstract] [Full-text]
6. Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms.
   Hepatology, 45(3): 623-30. [Abstract] [Full-text]
7. Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.
   Hepatology, 45(3): 614-22. [Abstract] [Full-text]
8. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
   Hepatology, 45(3): 602-13. [Abstract] [Full-text]
9. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
   Hepatology, 45(3): 588-601. [Abstract] [Full-text]
10. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
    Hepatology, 45(3): 569-78. [Abstract] [Full-text]
11. Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins.
    Cancer Lett, 248(1): 81-8. [Abstract] [Full-text]
12. Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants.
    J Immigr Minor Health, 9(3): 213-20. [Abstract] [Full-text]
13. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
    Clin Infect Dis, 44(7): 996-1000. [Abstract] [Full-text]
14. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Clin Infect Dis, 44(7): 988-95. [Abstract] [Full-text]
15. Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China.
    Int J Cancer, 120(9): 1981-5. [Abstract] [Full-text]
16. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Am J Med, 120(3): 280.e9-14. [Abstract] [Full-text]
17. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.
    Am J Med, 120(3): 272-9. [Abstract] [Full-text]
18. Evaluation of a pharmacist-managed hepatitis C care clinic.
    Am J Health Syst Pharm, 64(6): 632-6. [Abstract] [Full-text]
19. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.
    J Virol, 81(7): 3391-401. [Abstract] [Full-text]
20. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.
    J Virol, 81(7): 3662-6. [Abstract] [Full-text]
21. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    J Infect Dis, 195(8): 1181-3. [Abstract] [Full-text]
22. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Clin Oncol (R Coll Radiol), 19(3): 197-203. [Abstract] [Full-text]
23. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Ann Rheum Dis, 66(4): 511-6. [Abstract] [Full-text]
24. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis.
    Clin Infect Dis, 44(8): 1123-31. [Abstract] [Full-text]
25. Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study.
    BMC Public Health, 7: 32. [Abstract] [Full-text]
26. Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant.
    J Infect, 54(4): e223-6. [Abstract] [Full-text]
27. Differential dysfunction in dendritic cell subsets during chronic HCV infection.
    Clin Immunol, 123(1): 40-9. [Abstract] [Full-text]
28. A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C.
    Gut, 56(4): 553-9. [Abstract] [Full-text]
29. Referral for chronic hepatitis C treatment from a drug dependency treatment setting.
    Drug Alcohol Depend, 88(1): 49-53. [Abstract] [Full-text]
30. Screening for Rift Valley fever infection in northern Somalia: a GIS based survey method to overcome the lack of sampling frame.
    Vet Microbiol, 121(3): 249-56. [Abstract] [Full-text]
31. The role of cells refractory to productive infection in acute hepatitis B viral dynamics.
    Proc Natl Acad Sci U S A, 104(12): 5050-5. [Abstract] [Full-text]
32. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
    BMC Health Serv Res, 7: 39. [Abstract] [Full-text]
33. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Biol Blood Marrow Transplant, 13(4): 463-8. [Abstract] [Full-text]
34. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Int Immunopharmacol, 7(5): 578-87. [Abstract] [Full-text]
35. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
    Med Res Rev, 27(3): 353-73. [Abstract] [Full-text]
36. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
    Cancer, 109(7): 1360-4. [Abstract] [Full-text]
37. Separation of near full-length hepatitis C virus quasispecies variants from a complex population.
    J Virol Methods, 141(2): 220-4. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.